Clinical Infectious Diseases · 1993 · 55 citations · 14 references
Life SciencesImmunologyInfectious DiseasesAntimicrobial PharmacotherapyHost-pathogen InteractionsMedical MicrobiologyAntifungal PharmacotherapyAntifungal TherapyFungal ImmunologyFungal InfectionsFungal PathogenesisLiver TransplantationFungal Infections In Transplant RecipientsHost Defense ImpairmentInfection After TransplantationInfections After TransplantationInvasive Fungal InfectionsLiver Disease CoagulopathyMacrophage Function AlterationTransplant-associated Infections
Invasive aspergillosis developed in three (5%) of 55 adult liver transplant recipients at our institution. All three of our patients had concomitant candidemia and consumption coagulopathy, and invasive aspergillosis developed while they were receiving therapy with intravenous amphotericin B (0.5 mg/[kg.d]). The simultaneous occurrence of candidemia and invasive aspergillosis in liver transplant recipients may reflect a common defect in the host-defense mechanism against Candida and Aspergillus organisms (i.e., impaired phagocytic and mononuclear macrophage function) and liver disease per se. These three cases suggest that such low-dose intravenous amphotericin B will likely be ineffective if used as antifungal prophylaxis for invasive aspergillosis.
14
Infections after Liver Transplantation
Shimon Kusne, J. Stephen Dummer, Nina Singh et al. · Medicine · 1988 · 543 citations
Shimon Kusne, J. T. Cisneros, William Irish et al. · The Journal of Infectious Diseases · 1992 · 189 citations · Full text